(2023)
β-arrestin 2 negatively regulates lung cancer progression by inhibiting the TRAF6 signaling axis for NF-κB activation and autophagy induced by TLR3 and TLR4.
CELL DEATH & DISEASE.
14,
7
(2023)
FFAR2 antagonizes TLR2-and TLR3-induced lung cancer progression via the inhibition of AMPK-TAK1 signaling axis for the activation of NF-kappa B.
CELL AND BIOSCIENCE.
13,
1
(2023)
DNA double-strand break-free CRISPR interference delays Huntington’s disease progression in mice.
COMMUNICATIONS BIOLOGY.
6,
1
(2022)
Expanded targeting scope of LbCas12a variants allows editing of multiple oncogenic mutations.
MOLECULAR THERAPY-NUCLEIC ACIDS.
30,
-
(2022)
Targeted genomic translocations and inversions generated using a paired prime editing strategy.
MOLECULAR THERAPY.
